首页|FLOT1、PSMB4表达水平与膀胱癌患者临床病理特征及预后的研究

FLOT1、PSMB4表达水平与膀胱癌患者临床病理特征及预后的研究

扫码查看
目的 探究膀胱癌(BC)组织中浮舰蛋白-1(FLOT1)、蛋白酶体β亚基4型(PSMB4)的表达水平与BC患者的临床病理特征、预后的关系.方法 选择2017年6月至2022年6月在本院治疗的100例BC患者为研究对象,采用荧光定量PCR、免疫组化检测FLOT1、PSMB4蛋白在BC组织中的表达水平,分析FLOT1、PSMB4表达水平与BC临床病理特征的关系,采用Kaplan-Meier曲线分析FLOT1、PSMB4与BC患者预后的关系,采用Cox风险比例回归模型评估BC患者预后的影响因素.结果 癌组织中FLOT1、PSMB4 mRNA表达水平均明显高于癌旁组织(t=32.095、24.318,均P<0.05).癌组织中FLOT1、PSMB4阳性率均显著高于癌旁组织(x2=16.822、17.321,均P<0.001).癌组织中FLOT1、PSMB4表达水平均与肿瘤长径、病理分级、淋巴结是否转移、TNM分期均有相关性(均P<0.05).FLOT1、PSMB4阳性表达组的5年生存率均低于阴性表达组(均P<0.05).多因素分析结果显示,TNM分期、FLOT1、PSMB4阳性表达均是影响BC患者预后的独立危险因素(均P<0.05).受试者工作特征(ROC)曲线分析结果显示,FLOT1、PSMB4联合预测的曲线下面积(AUC)显著均高于单独指标预测(均P<0.05).结论 BC组织中FLOT1、PSMB4蛋白表达均升高,与BC病理分级、淋巴结转移、TNM分期及预后有关,为BC患者预后的独立危险因素,二者联合检测对BC患者不良预后的发生具有一定预测价值.
Study on the relationship between the expression of FLOT1 and PSMB4 in bladder cancer and the clinicopathologic features and prognosis
Objective To explore the relationship between the expression of Flotillin 1(FLOT1)and proteasome β subunit type 4(PSMB4)in bladder cancer(BC)and the clinicopatho-logical characteristics and prognosis of BC patients.Methods One-hundred BC patients who were treated in our hospital from June 2017 to June 2022 were selected as the study subjects.The expression of FLOT1 and PSMB4 proteins in BC tissue was detected by fluorescent quantitative PCR and immuno-histochemistry,the relationship between the expression of FLOT1,PSMB4 and the clinicopathological features of BC was analyzed.Kaplan-Meier curve was used to analyze the relationship between FLOT1,PSMB4 and the prognosis of BC patients.Cox risk proportional regression model was used to evaluate the prognostic factors of patients with BC.Results The expression of FLOT1 and PSMB4 in BC cancer tissue was significantly higher than that in adjacent tissues(t=32.095,24.318,all P<0.05).The positive rates of FLOT1 and PSMB4 in cancer tissues were significantly higher than those in adjacent tissues(x2=16.822,17.321,all P<0.001).The expression of FLOT1 and PSMB4 in cancer tissue is correlated with tumor length,pathological grade,lymph node metastasis,and TNM staging(all P<0.05).The 5-year survival rate of the positive FLOT1 expression group was lower than that of the neg-ative FLOT1 expression group(P<0.05).The 5-year survival rate of PSMB4-positive expression group was lower than that of negative expression group(P<0.05).The results of multi-factor analysis showed that TNM stage,FLOT1 and PSMB4 positive expression were independent risk factors for the prognosis of BC patients(all P<0.05).The results of receiver operating characteristic(ROC)curve showed that the area under the curve(AUC)of combined prediction was significantly higher than that of single prediction(all P<0.05).Conclusions The expression of FLOT1 and PSMB4 proteins in BC tissue is increased,which is related to the pathological grade,lymph node metastasis,TNM stage and prognosis of BC,and is an independent risk factor for the prognosis of BC patients.The combination of FLOT1 and PSMB4 protein has a certain predictive value for the occurrence of poor prognosis of BC.

Urinary Bladder NeoplasmsFlotillin 1Proteasome Subunit Beta Type 4

刘钰、汪厚志、赵行兵

展开 >

武汉市蔡甸区人民医院泌尿外科,武汉 430000

膀胱肿瘤 浮舰蛋白-1 蛋白酶体β亚基4型

2024

国际泌尿系统杂志
中华医学会,湖南省医学会

国际泌尿系统杂志

CSTPCD
影响因子:0.414
ISSN:1673-4416
年,卷(期):2024.44(5)
  • 2